It bears noting that SSc-related antibodies (including antibodies targeting GPCRs such as anti-ETAR and anti-AT1R) are quite refractory to conventional immunoadsorption, as their levels are rapidly restored once treatment is discontinued [98]. This evidence concerns the gene AGTR1 and systemic sclerosis.